Pharmacovigilance Learning Pathway

 Pharmacovigilance Regulatory Timelines Explained: Day 0, Day 7, Day 15, and Day 90 Reporting Pharmacovigilance regulatory timelines define how quickly adverse drug reactions must be reported to health authorities after they are identified. These timelines ensure that important safety information about medicines is communicated promptly, allowing regulators to assess risks and protect patient safety. In pharmacovigilance, reporting timelines are calculated from Day 0, which is the date when a valid Individual Case Safety Report (ICSR) is first received by the pharmacovigilance system. The most common reporting milestones include Day 7, Day 15, and Day 90.

  ICSR Processing in Pharmacovigilance: Step-by-Step Workflow for Beginners Introduction Pharmacovigilance focuses on the continuous monitoring of medicine safety in real-world use. One of the core activities in this field is the processing of Individual Case Safety Reports (ICSRs). An ICSR contains information about a suspected adverse drug reaction reported by a patient, healthcare professional, or other credible source, and it helps identify potential safety concerns related to medicinal products. ICSR processing involves a sequence of clearly defined steps, starting from the receipt of a case and continuing through data verification, medical assessment, regulatory reporting, and follow-up. Each step must be completed accurately and within regulatory timelines to ensure compliance and to support patient safety . In this blog, the ICSR processing workflow is explained in a step-by-step manner, highlighting how safety cases are handled in routine pharmacovigilance pract...

ADR Types in Pharmacovigilance (Type A–F) with Case Examples, ICSR Criteria & Dechallenge–Rechallenge Explained Introduction In pharmacovigilance, understanding adverse drug reactions (ADRs) is not just theoretical—it directly affects how cases are processed, assessed, and reported. Whether you are reviewing an Individual Case Safety Report (ICSR) or performing causality assessment, concepts like ADR classification, minimum reporting criteria, and dechallenge–rechallenge play a key role in decision-making. This article explains these concepts with practical examples to help you think like a drug safety professional. What is an Adverse Drug Reaction (ADR)? An ADR is a harmful and unintended response to a medicinal product where a causal relationship between the drug and the event is at least suspected. 👉 In real-world pharmacovigilance: You don’t always prove causality—you assess whether it is reasonably possible . To understand the basic pharmacovigilance terminology used in ...

 Key Terminologies in Pharmacovigilance Explained (ADR, AE, SAE, SUSAR, ICSR Guide) Pharmacovigilance involves monitoring the safety of medicines and identifying adverse effects associated with drug use. To understand drug safety reporting, it is important to learn the key pharmacovigilance terminologies used in clinical trials and post-marketing surveillance. In this guide, we explain important pharmacovigilance terms such as Adverse Event (AE), Adverse Drug Reaction (ADR), Serious Adverse Event (SAE), SUSAR, ICSR, signal detection, and risk management with practical examples for beginners.

Introduction Pharmacovigilance (PV) is an essential discipline in healthcare that focuses on ensuring the safety of medicines. Since no drug is completely free from risk, continuous monitoring is required to detect and prevent adverse effects and to protect patients and public health. This blog explains the basic concepts of Pharmacovigilance, including its definition, objectives, scope, types, and historical background. It is especially useful for students, freshers, and beginners in Pharmacovigilance.